A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)
Clinical trial NCT03480763 · COMPLETED
Trial details
- NCT number
- NCT03480763
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-22
- Primary completion
- 2019-12-23
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.